hydralazine has been researched along with Sepsis in 9 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sepsis is an amplified systemic immune-inflammatory response produced by a microorganism, which involves activation of inflammatory cytokine signaling pathways and oxidative stress." | 5.62 | The Therapeutic Value of Hydralazine in Reducing Inflammatory Response, Oxidative Stress, and Mortality in Animal Sepsis: Involvement of the PI3K/AKT Pathway. ( Assreuy, J; Da Silva, EAP; Heimfarth, L; Júnior, LJQ; Marinho, YYM; Menezes, IAC; Oliveira, JYS; Pereira, EWM; Santana, IR; Santos, DMD; Santos, MRVD, 2021) |
| "Sepsis is an amplified systemic immune-inflammatory response produced by a microorganism, which involves activation of inflammatory cytokine signaling pathways and oxidative stress." | 1.62 | The Therapeutic Value of Hydralazine in Reducing Inflammatory Response, Oxidative Stress, and Mortality in Animal Sepsis: Involvement of the PI3K/AKT Pathway. ( Assreuy, J; Da Silva, EAP; Heimfarth, L; Júnior, LJQ; Marinho, YYM; Menezes, IAC; Oliveira, JYS; Pereira, EWM; Santana, IR; Santos, DMD; Santos, MRVD, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HC | 1 |
| Hsiao, TS | 1 |
| Liao, MH | 1 |
| Tsao, CM | 1 |
| Shih, CC | 1 |
| Wu, CC | 1 |
| Santos, DMD | 1 |
| Da Silva, EAP | 1 |
| Oliveira, JYS | 1 |
| Marinho, YYM | 1 |
| Santana, IR | 1 |
| Heimfarth, L | 1 |
| Pereira, EWM | 1 |
| Júnior, LJQ | 1 |
| Assreuy, J | 1 |
| Menezes, IAC | 1 |
| Santos, MRVD | 1 |
| FIASCHI, E | 1 |
| GRASSI, B | 1 |
| ANDRES, G | 1 |
| RIVA, HL | 1 |
| PICKHARDT, WL | 1 |
| HOLZWORTH, RH | 1 |
| SHERMAN, RL | 1 |
| JOHNSON, GT | 1 |
| THOMPSON, RB | 1 |
| GRODY, MH | 1 |
| BECK, L | 1 |
| MACLAVERTY, MP | 1 |
| PAVLIC, RS | 1 |
| SMITH, CJ | 1 |
| Diethelm, AG | 1 |
| Hartley, MW | 1 |
| Aldrete, JS | 1 |
| Sterling, WA | 1 |
| Morgan, JM | 1 |
9 other studies available for hydralazine and Sepsis
| Article | Year |
|---|---|
Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative/nitrosative properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Thoracic; Blood Coagulation Disorders; Blood | 2020 |
The Therapeutic Value of Hydralazine in Reducing Inflammatory Response, Oxidative Stress, and Mortality in Animal Sepsis: Involvement of the PI3K/AKT Pathway.
Topics: Animals; Hydralazine; Inflammation; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene | 2021 |
[Hydrazinophthalazine in the treatment of glomerulonephritis caused by focal sepsis].
Topics: Glomerulonephritis; Hydralazine; Pharyngeal Diseases; Pharynx; Sepsis; Sympatholytics | 1955 |
Further experience with apresoline in toxemia and hypertension of pregnancy.
Topics: Female; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Sepsis; Sympat | 1956 |
A clinical trial of intravenous apresoline in the management of toxaemia of late pregnancy.
Topics: Bacterial Infections; Disease Management; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Sep | 1958 |
Antihypertensive drugs in toxemia: a practical integrated plan of management.
Topics: Antihypertensive Agents; Bacterial Infections; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy | 1959 |
[Can infant mortality in late pregnancy toxemia be reduced by treatment with hypotensive drugs].
Topics: Antihypertensive Agents; Bacterial Infections; Female; Hydralazine; Infant Mortality; Pre-Eclampsia; | 1959 |
PROGRAM FOR TOXEMIA CONTROL: STUDY OF 551 CASES.
Topics: Anticonvulsants; Delivery, Obstetric; Drug Therapy; Eclampsia; Female; Humans; Hydralazine; Pre-Ecla | 1965 |
Treatment of accelerated hypertension and end stage renal failure by bilateral nephrectomy and renal transplantation.
Topics: Acute Kidney Injury; Adult; Biopsy; Blood Pressure; Child; Creatinine; Female; Graft Rejection; Guan | 1975 |